Home » Drug Information » Recently Approved Drugs » 1999
Medical Areas: Cardiology/Vascular Diseases
Drug Information
The following information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
Company: Merck
Approval Status: Approved March 1999
Treatment Area: Cardiology
Mevacor has been approved for the primary prevention of coronary
heart disease in patients without symptomatic cardiovascular
disease who have average to moderately elevated total-C and LDL-C
and below average HDL-C.
